Lamina Vii Preganglionic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Lamina VII preganglionic neurons are a critical population of autonomic neurons located in the spinal cord's lamina VII (the intermediate zone), serving as the central origin of sympathetic and parasympathetic efferents that regulate visceral organ function. These neurons are essential for maintaining autonomic homeostasis, controlling functions ranging from cardiovascular regulation to gastrointestinal motility, and are profoundly affected in several neurodegenerative diseases, particularly Multiple System Atrophy (MSA) and Parkinson's Disease (PD) [1][2].
¶ Anatomy and Location
Lamina VII occupies the intermediate zone of the spinal cord gray matter, situated between the dorsal horn (laminae I-VI) and the ventral horn (laminae VIII-IX). This region is anatomically positioned to integrate sensory information with motor output, making it crucial for autonomic reflex circuits [3].
Key anatomical features:
- Located primarily in the thoracic and lumbar enlargements for sympathetic preganglionic neurons
- Parasympathetic preganglionic neurons concentrated in sacral spinal cord (S2-S4)
- Neuronal cell bodies are predominantly large, multipolar neurons
- Dendritic arborizations extend into adjacent laminae for synaptic integration
- Location: Thoracic and upper lumbar spinal cord (T1-L2)
- Target: Sympathetic chain ganglia and prevertebral ganglia
- Function: Regulate heart rate, blood pressure, pupil dilation, sweating, gastrointestinal motility
- Location: Sacral spinal cord (S2-S4)
- Target: Pelvic ganglia and terminal ganglia
- Function: Control bladder voiding, defecation, sexual function
Primary neurotransmitter: Acetylcholine (ACh)
- Released at both central synapses and ganglionic targets
- Acts on nicotinic ACh receptors in autonomic ganglia
- Muscarinic receptors mediate slow synaptic responses [4]
¶ Co-transmitters and Modulators
| Transmitter |
Function |
| Cholecystokinin (CCK) |
Neuromodulation, anxiety-related behavior |
| Cocaine- and Amphetamine-Regulated Transcript (CART) |
Energy homeostasis, pain modulation |
| Neurotensin |
Thermoregulation, pain processing |
| Somatostatin |
Inhibitory modulation |
- Nicotinic receptors: α3β4, α3β2, α7 subunits predominate
- Muscarinic receptors: M1-M5 subtypes with differential expression
- Adrenergic receptors: α2A, α2C for presynaptic modulation
- Serotonergic receptors: 5-HT1A, 5-HT2 for descending modulation
¶ Function and Pathways
Lamina VII preganglionic neurons participate in several crucial reflex arcs:
Baroreceptor → NTS → RVLM → IML → SPN → Sympathetic Ganglia → Target Organ
Baroreflex arc:
- Maintains blood pressure homeostasis
- Rapid adjustments to posture changes
- Dysfunction leads to orthostatic hypotension
These neurons receive convergent input from:
- Visceral afferents (via dorsal root ganglia)
- Supraspinal autonomic centers (hypothalamus, parabrachial nucleus)
- Spinal interneurons in laminae V-VII
- Cardiac accelerator neurons (T1-T4): Increase heart rate and contractility
- Vasoconstrictor neurons: Regulate blood vessel tone
- Vasodilator neurons: Modulate blood flow to specific regions
- Bronchial smooth muscle tone
- Tracheal gland secretion
- Interaction with respiratory centers
- Inhibition of peristalsis (sympathetic)
- Promotion of peristalsis and secretion (parasympathetic)
- Sphincter control
- Bladder wall contraction (parasympathetic)
- Internal urethral sphincter contraction (sympathetic)
- External urethral sphincter (somatic, Onuf's nucleus)
- Tonically active neurons: Continuous firing at 2-10 Hz
- Phasic neurons: Burst firing related to specific reflexes
- Silent neurons: Activated only during specific behaviors
- Resting membrane potential: -55 to -65 mV
- Input resistance: 50-200 MΩ
- Action potential duration: 1-2 ms
- Afterhyperpolarization: 100-300 ms
¶ Development and Plasticity
- Derived from neural tube
- Migration to final position during development
- Axonal outgrowth to target ganglia
- Synaptic strength modifications in autonomic pathways
- Target-derived trophic factor dependence
- Experience-dependent remodeling
MSA is characterized by profound autonomic failure due to degeneration of preganglionic autonomic neurons [1][5]:
Pathological features:
- Loss of cholinergic neurons in intermediolateral cell column
- Degeneration of sympathetic ganglionic neurons
- Associated with oligodendroglial α-synuclein inclusions
Clinical manifestations:
- Neurogenic orthostatic hypotension
- Urinary incontinence/retention
- Erectile dysfunction
- Reduced sweating (anhidrosis)
Mechanisms:
- Primary neurodegeneration of preganglionic neurons
- Secondary effects from central autonomic pathway degeneration
- α-Synuclein toxicity to autonomic neurons
PD involves autonomic dysfunction that correlates with disease progression [2][6]:
Autonomic features:
- Constipation (most common early symptom)
- Orthostatic hypotension
- Urinary dysfunction
- Sexual dysfunction
- Sweating abnormalities
Pathological mechanisms:
- Lewy body pathology in autonomic ganglia
- Degeneration of vagal preganglionic neurons
- Peripheral autonomic neuropathy
Autonomic dysfunction in AD [7]:
- Reduced heart rate variability
- Orthostatic hypotension
- Sleep fragmentation related to autonomic dysregulation
- Possible vagus nerve involvement in disease spread
Autonomic involvement in ALS [8]:
- Cardiovascular dysautonomia
- Urinary dysfunction in later stages
- May reflect brainstem/spinal cord involvement
While not a primary neurodegenerative disease:
- Similar patterns of preganglionic neuron dysfunction
- Loss of autonomic reflexes
- Targets same neuronal populations
- α2-Adrenergic agonists: Modulate sympathetic output
- Muscarinic agonists: Treat dry mouth, bladder dysfunction
- Cholinesterase inhibitors: Enhance ganglionic transmission
- Fludrocortisone: Treat orthostatic hypotension
- Pacemakers: Cardiac rhythm management
- Deep brain stimulation: May modulate autonomic centers
- Spinal cord stimulation: Potential for autonomic regulation
- Gene therapy: Targeting autonomic ganglia
- Cell replacement: Stem cell-derived preganglionic neurons
- Neuroprotective agents: NGF, BDNF for autonomic neurons
| Method |
Application |
| Electrophysiology |
Characterize firing properties |
| Tracing studies |
Map connectivity |
| Immunohistochemistry |
Identify neurotransmitter phenotypes |
| Calcium imaging |
Monitor activity in vivo |
| Optogenetics |
Selective manipulation |
- Transgenic α-synuclein models
- Rotenone/MPTP models
- Genetic models of autonomic dysfunction
[1] Wenning et al., Multiple System Atrophy (2014)
[2] Jost & Taggart, Autonomic dysfunction in PD (2012)
[3] Llewellyn-Smith et al., Preganglionic neuron anatomy (2015)
[4] Sheng et al., Nicotinic receptors in autonomic ganglia (2013)
[5] Krismer & Wenning, MSA autonomic failure (2017)
[6] Chen et al., Autonomic dysfunction in PD (2020)
[7] Algotsson et al., Autonomic function in AD (2015)
[8] Baltzegar et al., Autonomic dysfunction in ALS (2018)
Lamina Vii Preganglionic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Lamina Vii Preganglionic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Nattie E, et al. Autonomic control of sympathetic preganglionic neurons. Prog Brain Res. 1996;107:87-111. PMID:8782509
2.Strack AM, et al. Distribution of preganglionic autonomic neurons. J Comp Neurol. 1988;277(1):125-138. PMID:3192750